Annals of the New York Academy of Sciences · 2009 · 59 citations · 27 references
Veterinary MedicineHematologyInfectious DiseasesHost-pathogen InteractionsMolecular VirologyVirologyInfectious Disease PathophysiologyPlatelet ActivationPlatelet FunctionPlatelet PhysiologyViral InfectionsViral PathogenesisClinical SymptomsDengue FeverDengue Hemorrhagic FeverHemorrhagic Manifestations
Viremia is one of the features of dengue virus infection among the flaviviruses. Dengue virus infection results in a spectrum of clinical symptoms, ranging from undifferentiated flu-like illness, mild dengue fever, to dengue hemorrhagic fever (DHF)/dengue shock syndrome (DSS), a life-threatening illness. Several mechanisms have been hypothesized based primarily on data collected from post-acute clinical phase to account for DHF/DSS. Lack of a suitable animal model for DHF/DSS has hindered progress in defining the etiology of DHF/DSS. Levels of circulating dengue virus have been well-correlated to severe dengue disease. However, the cell lineage(s) serving as a primary target for the source of viremia are largely unknown. Results from in vivo and in vitro pilot studies using molecular and more advanced technologies reveal that dengue virus appears to be associated with platelets and the megakaryocytic lineage. The observation may partially explain the dysfunction of platelets observed in dengue affected patients.
27
Human skin Langerhans cells are targets of dengue virus infection
Shuenn-Jue L. Wu, Géraldine Grouard-Vogel, Wellington Sun et al. · Nature Medicine · 2000 · 671 citations
Platelet-Mediated Modulation of Adaptive Immunity
Bennett D. Elzey, Jun Tian, Robert J. Jensen et al. · Immunity · 2003 · 392 citations · Full text
David M. Morens, Anthony S. Fauci · JAMA · 2008 · 186 citations
Medicine, Dermatology, Neurology +8
Viruses and bone marrow failure
Neal S. Young, Philip P. Mortimer · Blood · 1984 · 175 citations · Full text